Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$1.17 - $1.65 $3,694 - $5,210
-3,158 Reduced 16.67%
15,790 $18,000
Q1 2024

May 15, 2024

SELL
$1.15 - $2.19 $3,630 - $6,913
-3,157 Reduced 14.28%
18,948 $28,000
Q4 2023

Feb 14, 2024

SELL
$0.93 - $2.35 $2,936 - $7,418
-3,157 Reduced 12.5%
22,105 $46,000
Q2 2023

Aug 14, 2023

BUY
$1.8 - $3.19 $22,735 - $40,292
12,631 Added 100.0%
25,262 $47,000
Q1 2023

May 15, 2023

SELL
$2.01 - $4.17 $25,388 - $52,671
-12,631 Reduced 50.0%
12,631 $34,000
Q3 2020

Nov 13, 2020

SELL
$13.63 - $24.12 $9.69 Million - $17.2 Million
-711,076 Reduced 96.57%
25,262 $548,000
Q2 2020

Aug 12, 2020

SELL
$7.65 - $14.11 $5.29 Million - $9.75 Million
-690,881 Reduced 48.41%
736,338 $9.55 Million
Q2 2019

Aug 12, 2019

BUY
$27.0 - $30.25 $38.5 Million - $43.2 Million
1,427,219 New
1,427,219 $38.7 Million

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $171M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Board Of Trustees Of The Leland Stanford Junior University Portfolio

Follow Board Of Trustees Of The Leland Stanford Junior University and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Board Of Trustees Of The Leland Stanford Junior University, based on Form 13F filings with the SEC.

News

Stay updated on Board Of Trustees Of The Leland Stanford Junior University with notifications on news.